| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host. | Haematologica | 2010 | 1.08 |
| 2 | Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. | Biol Blood Marrow Transplant | 2010 | 0.95 |
| 3 | Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling. | Blood | 2013 | 0.85 |
| 4 | Humoral and cellular immunity to primary H1N1 infection in patients with hematologic malignancies following stem cell transplantation. | Biol Blood Marrow Transplant | 2010 | 0.84 |
| 5 | Dasatinib may overcome the negative prognostic impact of KIR2DS1 in newly diagnosed patients with chronic myeloid leukemia. | Blood | 2012 | 0.76 |